Research Outputs

Permanent URI for this communityhttps://hdl.handle.net/20.500.14288/2

Browse

Filters

20201

Advanced Search

Filter by

Settings

Department: search.filters.department.Department of ChemistrySubject: search.filters.subject.Medicinal

Search Results

Now showing 1 - 1 of 1
  • Placeholder
    PublicationMetadata only
    Resorufin enters the photodynamic therapy arena: a monoamine oxidase activatable agent for selective cytotoxicity
    (Amer Chemical Soc, 2020) Atakan, Gizem; Gunbas, Gorkem; Department of Chemistry; N/A; N/A; Department of Chemistry; Almammadov, Toghrul; Leylek, Özen; Özcan, Gülnihal; Kölemen, Safacan; Researcher; PhD Student; Faculty Member; Faculty Member; Department of Chemistry; Koç University Surface Science and Technology Center (KUYTAM) / Koç Üniversitesi Yüzey Teknolojileri Araştırmaları Merkezi (KUYTAM); Koç University Boron and Advanced Materials Application and Research Center (KUBAM) / Koç Üniversitesi Bor ve İleri Malzemeler Uygulama ve Araştırma Merkezi (KUBAM); Koç University Tüpraş Energy Center (KUTEM) / Koç Üniversitesi Tüpraş Enerji Merkezi (KÜTEM); College of Sciences; Graduate School of Health Sciences; School of Medicine; College of Sciences; N/A; N/A; 185014; 272051
    A red-absorbing, water-soluble, and iodinated resorufin derivative (R1) that can be selectively activated with a monoamine oxidase (MAO) enzyme was synthesized, and its potential as a photodynamic therapy (PDT) agent was evaluated. R1 showed high O-1(2) generation yields in aqueous solutions upon addition of MAO isoforms, and it was further tested in cell culture studies. R1 induced photocytotoxicity after being triggered by endogenous MAO enzyme in cancer cells with a much higher efficiency in SH-SYSY neuroblastoma cells with high MAO-A expression. Additionally, R1 displayed differential cytotoxicity between cancer and normal cells, without any considerable dark toxicity. To the best of our knowledge, R1 marks the first example of a resorufin-based photosensitizer (PS) as well as the first anticancer drug that is activated by a MAO enzyme. Remarkably, the target PDT agent was obtained only in three steps as a result of versatile resorufin chemistry.